Skip to main content
. 2022 Sep 12;14(9):1927. doi: 10.3390/pharmaceutics14091927

Table 4.

Characterization of tadalafil-loaded liquid self-nanoemulsifying drug delivery systems (TDL-L-SNEDDS) formulations.

Code VO PT (%) SET (Sec) Robustness
to Dilution
ADS (nm) PDI ZP (mV) Thermodynamic Stability Tests
H/C CT F/T Test
F1 B 90.1 ± 1.7 39 ± 0.33 No 198 ± 8.7 4.5 ± 1.80 −4.7 ± 0.3 X - -
F2 B 92.3 ± 2.4 37 ± 0.43 Yes 222 ± 7.6 3.20 ± 0.97 −5.8 ± 0.27 X -
F3 A 95.7 ± 1.1 29 ± 0.37 Yes 159 ± 4.7 0.24 ± 0.03 −11.9 ± 0.82
F4 A 96.3 ± 1.6 25 ± 0.77 Yes 132 ± 6.8 0.45 ± 0.09 −17.8 ± 0.18
F5 A 97.9 ± 1.3 23 ± 0.34 Yes 45 ± 6.9 1.24 ± 0.16 −18.1 ± 0.25
F6 A 98.8 ± 1.8 20 ± 0.29 Yes 32 ± 4.6 1.35 ± 0.37 −19.7 ± 0.41

Mean ± SD; n = 3; SD, standard deviation; L-SNEDD, liquid self-nanoemulsifying drug delivery systems; VO, visual observation; PT, percentage transmittance; SET, self-emulsification time; AGS, average droplet size (ADS); PDI, polydispersity index; ZP, zeta potential; CT, centrifugation test; H/C cycle, heating cooling test; F/T test, freeze/thaw test.